Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Ovarian Autologous PRP vs Gonadotropin in Letrozole-Resistant PCOS
NCT07777640Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jun 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous platelet-rich plasma in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Proportion of Participants With Developing Follicles >=14 mm, Proportion of Participants With Mature Follicles and 2 more. Started Jun 2025; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07777640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07777640.